Alzheimer's disease fueled by gut bacteria, new study finds
Just One More Thing...We have sent you a verification email. If you do not receive the verification message within a few minutes of signing up, please check your Spam or Junk folder. Please check your email and click on the link to activate your PalmBeachPost.com profile.
Old, generic drug for rare disease gets new price tag: $89,000 per year
Other drugs treat Duchenne, which is a severe type of muscular dystrophy that mostly affects boys (it's X-linked recessive). Well, one of its members just took an old, cheap drug and priced a year's worth of it at $89,000. The voucher is meant to incentivize drug companies to develop treatments for rare diseases. Further Reading Pharma companies disown Shkreli; Pissed, Shkreli airs their dirty laundryThe steroid drug, deflazacort, which treats Duchenne muscular dystrophy, has been approved overseas for years and is sold as a generic. But Marathon Pharmaceuticals (a member of the PhRMA trade group) finally got it FDA-approved Thursday under an "orphan drug" status, which covers drugs that treat rare diseases.about the details read more from here
collected by :Lucy William
No comments:
Post a Comment